Acceleron Pharma
XLRN
#1821
Rank
A$16.51 B
Marketcap
A$270.06
Share price
0.00%
Change (1 day)
14,660.36%
Change (1 year)

Earnings for Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -A$0.35 Billion

According to Acceleron Pharma's latest financial reports the company's current earnings are A$0.11 Billion. In 2020 the company made an earning of -A$0.26 Billion a decrease over its 2019 earnings that were of -A$0.21 Billion.

Earnings history for Acceleron Pharma from 2012 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.35 Billion35%
2020-A$0.26 Billion22.62%
2019-A$0.21 Billion9.67%
2018-A$0.19 Billion13.12%
2017-A$0.17 Billion92.99%
2016-A$86.11 Million-6.39%
2015-A$91.99 Million20.95%
2014-A$76.05 Million154.15%
2013-A$29.93 Million-36.22%
2012-A$46.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B-7,427.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B-2,827.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.69 B-4,425.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$8.59 B-2,325.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-A$0.31 Billion-21.79%๐Ÿ‡บ๐Ÿ‡ธ USA